SKAN Group AGFRA:7VG +2.61%66 Receivables Turnover is 7.53 as of Dec. 2025. GuruFocus rates FRA:7VG with a GF Score™ of 66/100 and a GF Value™ of €90.96 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 813 Medical Devices & Instruments companies, SKAN Group AG ranks better than 92.37% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. SKAN Group AG's Revenue for the
six
months ended in Dec. 2025 was €213.0 Mil. SKAN Group AG's average Accounts Receivable for the
six
months ended in Dec. 2025 was €28.3 Mil.
Hence, SKAN Group AG's Receivables Turnover for the
six
months ended in Dec. 2025 was 7.53.
SKAN Group AG (FRA:7VG) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
SKAN Group AG Receivables Turnover Related Terms
SKAN Group AG Receivables Turnover Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7VG vs ISRG, BDX, MDLN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, SKAN Group AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (FRA:7VG) has a Receivables Turnover of 7.53 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SKAN Group AG and its competitors. According to the industry distribution chart, SKAN Group AG ranks #62 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is SKAN Group AG's Receivables Turnover too high?
SKAN Group AG's current Receivables Turnover is 7.53. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. SKAN Group AG's value of 7.53 is 36.7% above this industry median. Based on the distribution chart, SKAN Group AG ranks #62 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SKAN Group AG has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #62 out of 813 companies for Receivables Turnover. This places SKAN Group AG in the top 8% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. SKAN Group AG's value of 7.53 is 36.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current Receivables Turnover of 7.53 is 36.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current Receivables Turnover is 7.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.96, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current Receivables Turnover is 7.53 and 36.7% above the Medical Devices & Instruments industry median of 5.51. SKAN Group AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current Receivables Turnover is 7.53 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (FRA:7VG) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.96.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for FRA:7VG:
Receivables Turnover: 7.53
GF Value™: €90.96 vs. price of €59.00 (35.1% below fair value)
Industry Position: 36.7% above the Medical Devices & Instruments median (#62 of 813)
No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
66GF Score
Get the complete analysis for FRA:7VG
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7VG has been successfully added to your 
